| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Fujun Wang CEO | XSHE Exchange | CNE100000NJ9 ISIN |
| CN Country | 1,604 Employees | 28 Apr 2026 Last Dividend | 28 Apr 2026 Last Split | 23 Apr 2010 IPO Date |
Tianjin Lisheng Pharmaceutical Co.,Ltd. is a prominent entity in China's pharmaceutical landscape, focusing on the research and development, production, and sales of a diverse range of pharmaceutical products. Established in 1951 and headquartered in Tianjin, China, the company has amassed extensive experience in the pharmaceutical industry, becoming a trusted name among healthcare professionals and patients alike. Operating as a subsidiary of Tianjin Jinhao Pharmaceutical Co., Ltd., Tianjin Lisheng Pharmaceutical has a wide-reaching impact in the medical field, significantly contributing to the well-being of individuals through its innovative healthcare solutions. Besides serving the domestic market, the company has made a mark on the international stage by exporting its products, showcasing its commitment to improving global health.
Tianjin Lisheng Pharmaceutical Co.,Ltd. offers an extensive portfolio of pharmaceutical products, catering to a broad spectrum of therapeutic fields. Each product form and category are designed to meet the varying needs of patients and healthcare providers. The company's product lineup includes: